Table 2. Association between demographic characteristics, medical history, current health status, self-care knowledge, ability to meet basic needs, and self-care practices (n=200)

Characteristic Self-care practice Univariable logistic regression Multivariable logistic regression
Poor (n=152) Good (n=48) OR p-value CI 95% OR p-value CI 95%
Age Mean±SD: 57.8±11.4 (Min-max: 25–93)
 Under 50 years 26 (17.1) 18 (37.5) 1 - - 1 - -
 50 to <60 years 52 (34.2) 13 (27.1) 0.36 0.02 0.15–0.85 0.30 0.127 0.06–1.41
 60 years and older 74 (48.7) 17 (35.4) 0.33 0.007 0.15–0.74 0.73 0.756 0.10–5.35
Gender
 Male 96 (63.2) 34 (70.8) 1 - -
 Female 56 (36.8) 14 (29,2) 0.71 0.332 0.35–1.43
Marital status
 Single/widowed 17 (11.2) 7 (14.6) 1 - -
 Married 135 (88.8) 41 (85.4) 0.74 0.529 0.29–1.90
Cohabiting
 Other relatives 33 (21.7) 14 (29.2) 1 - -
 Spouse 119 (78.3) 34 (70.8) 0.67 0.290 0.32–1.40
Residence
 Rural 116 (76.3) 22 (45.8) 1 - - 1 - -
 Urban 36 (23.7) 26 (54.2) 3.81 <0.001 1.93–7.52 2.54 0.2 0.61–10.5
Monthly income
 Low 30 (19,7) 6 (12.5) 1 - -
 Average 47 (30.9) 7 (14.6) 0.75 0.625 0.23–2.43
 Above average 75 (49.4) 35 (72.9) 2.33 0.085 0.89–6.12
Employment status
 Unemployed/retired 110 (72.4) 21 (43.8) 1 - - 1 - -
 Employed 43 (27.6) 27 (56.2) 3.37 <0.001 1.72–6.59 4.05 0.045 1.82–10.1
Education level
 Primary or lower 64 (42.1) 7 (14.6) 1 - - 1 - -
 Secondary school 66 (43.4) 9 (18.8) 1.25 0.679 0.44–3.55 1.01 0.991 0.10–7.34
 High school 13 (8.6) 18 (37.5) 12.7 <0.001 4.40–36.4 9.72 0.001 3.62–9.62
 University or higher 9 (5.9) 14 (29.1) 14.2 <0.001 4.53–44.7 5.38 0.008 3.46–35.3
Family history of cancer
 No 114 (75.0) 21 (43.8) 1 - - 1 - -
 Yes 38 (25.0) 27 (56.3) 3.86 <0.001 1.96–7.60 3.76 0.037 1.08–13.1
Chronic Illness
 No 105 (69.1) 30 (62.5) 1 - -
 Yes 47 (30.9) 18 (37.5) 1.34 0.397 0.68–2.64
Chemotherapy duration
 Less than 6 months 95 (62.5) 33 (68.8) 1 - -
 From 6 months to 1 year 41 (27.0) 13 (27.1) 0.91 0.809 0.44–1.91
 More than 1 year 16 (10.5) 2 (4.1) 0.36 0.188 0.08–1.65
Number of chemotherapy doses per month
 1 dose 142 (93.4) 43 (89.6) 1 - -
 2 doses 10 (6.6) 5 (10.4) 1.65 0.383 0.54–5.09
Improvement after chemotherapy
 No 37 (24.3) 10 (20.8) 1 - -
 Yes 115 (75.7) 38 (79.2) 1.22 0.618 0.56–2.69
Onset of side effects
 Immediately after administration 41 (27.0) 15 (31.3) 1 - -
 Within 1 week 98 (73.0) 32 (68.8) 0.89 0.755 0.44–1.82
Duration of side effects
 1–3 days 58 (38.2) 24 (50.0) 1 - - 1 - -
 1 week 60 (39.5) 20 (41.7) 0.81 0.542 0.4–1.61 0.44 0.263 0.11–1.85
 2 weeks or more 29 (19.1) 4 (8.3) 0.33 0.061 0.11–1.05 0.05 0.014 0.01–0.55
 Knowledge about chemotherapy & self-care Mean±SD: 4.3±0.9 2.80 <0.001 2.02–3.90 3.01 <0.001 1.80–5.04
 Ability to meet basic needs Mean±SD: 21.4±3.3 4.09 <0.001 2.04–8.18 5.31 0.004 1.71–16.5
CIs, confidence intervals.